Merck stock gains on COVID pill hopes – is MRK stock a game changer?
Merck & Co. (NYSE: MRK) shares jumped more than 8% on Friday, after the company released an update regarding its experimental Covid-19 antiviral oral drug molnupiravir. The interim analysis from the Phase 3 trial found Molnupiravir may prevent the chances of hospitalization or death from COVID-19 by 50% among people who are at high risk …
Merck stock gains on COVID pill hopes – is MRK stock a game changer? Read More »